/Companies

Ori Biotech

8 known investors

Find your way into Ori Biotech

Sign up to see every warm intro you have to Ori Biotech

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ori Biotech team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.

Investors · 8

Also in the syndicate · 1

Chimera Abu Dhabi

Funding

SEC filings, press & company announcements

$100M disclosed across 1 of 2 rounds · 2020–2022

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Ori Biotech do?
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Who are Ori Biotech's investors?
Ori Biotech's investors include Amadeus Capital Partners, Kindred Capital, Novalis LifeSciences, Octopus Ventures, Delin Ventures, Northpond Ventures, Puhua Capital.
How much funding has Ori Biotech raised?
Ori Biotech has disclosed $100M raised across 1 of its 2 known rounds.